EDCTP-PLUS

EDCTP-Plus: Laying the foundations for the EDCTP-II programme

Coordinatore	EDCTP-EEIG    more  Organization address address: LAAN VAN NIEUW OOST INDIE 334 city: DEN HAAG postcode: 2593 CE contact info Titolo: Mr. Nome: Abdoulie Cognome: Barry Email: send email Telefono: +31 70 344 08 96
Nazionalità Coordinatore	Netherlands [NL]
Totale costo	7˙734˙128 €
EC contributo	7˙734˙128 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-Adhoc-2007-13
Funding Scheme	CSA-SA
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-01-01   -   2014-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	EDCTP-EEIG  Organization address address: LAAN VAN NIEUW OOST INDIE 334 city: DEN HAAG postcode: 2593 CE contact info Titolo: Mr. Nome: Abdoulie Cognome: Barry Email: send email Telefono: +31 70 344 08 96	NL (DEN HAAG)	coordinator	7˙734˙128.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Background: The European and Developing Countries Clinical Trials Partnership (EDCTP) was established by the European Union in 2003 in response to the global health crisis caused by the major three poverty-related diseases (PRDs) HIV/AIDS, tuberculosis and malaria and as the first initiative based on Article 185 (ex-Art. 169) of the Treaty on the Functioning of the European Union (TFEU) aimed at EU financial support for programmes undertaken by several EU Member States.

Aim: The coordination and support action, EDCTP-Plus, refers to a programme of activities to be carried out during the period 2012-2014 in preparation for the anticipated second phase of EDCTP (EDCTP-II) which will be funded through Horizon2020 and thus not start before January 2014.

Methods: Activities will be undertaken to establish a strong and reliable foundation for a second phase of the EDCTP Programme, which is expected to have an expanded EU mandate and budgetary support. The objectives of the project are: • To develop integration and funding strategies through the mapping of and cooperation between national programmes and research activities to address the major poverty-related and neglected infectious diseases • To enhance future cooperation and synergy with industry, like-minded organisations, non-EDCTP partner countries and other funding agencies and stakeholders working on poverty-related and neglected infectious diseases • To strengthen the capacity development, coordination and networking activities undertaken by the current EDCTP programme in coordination with other organisations • To increase awareness and profile of EDCTP, its achievements and impact, including through a high-level conference in Brussels involving political representation by all parties with an interest in EDCTP • To improve and update EDCTP's strategic and operational implementation processes and systems in view of the expected expansion of remit with EDCTP-II • To develop a robust evaluation framework for monitoring and evaluation of the impact of EDCTP- II.

Impact: The expected impact will be a maintained profile of the EU-Africa research partnership and a strengthened foundation to underpin and implement the EDCTP-II programme with an expanded scope and budget.  '